Utilitzem cookies
Aquest lloc web utilitza cookies per a oferir-vos la informació més rellevant. Si vosté continua navegant, accepta aquestes cookies.
Aquest lloc web utilitza cookies per a oferir-vos la informació més rellevant. Si vosté continua navegant, accepta aquestes cookies.
Ho sabíeu?
Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Podeu fer doble clic en una paraula per a buscar-la a TermGallery.
Significats de bortezomib en anglès
Sinònims
Examples for "peptide boronate"
Examples for "peptide boronate"
1
The inhibitors tested included several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far.
1
TUNEL staining indicated that PS-341 treatment sensitizes Tax tumors to DNA fragmentation.
2
In Tax transgenic mice, PS-341 administered thrice weekly inhibited tumor-associated NF-kappaB activity.
3
PSI suppressed the growth of AML cell lines more effectively than PS-341.
4
Both preclinical and clinical studies of novel agents including PS-341 and IMiDs are highlighted.
5
The tumor tissues treated with PS-341 show no consistent inhibition of NFkappaB activation in vivo.
Ús de bortezomib en anglès
1
These biomarkers data begin to illuminate bortezomib's mechanism of action in lymphoma.
2
Results: Thirty-one per cent of patients received bortezomib beyond first relapse.
3
However, apoptotic response to bortezomib was not affected by the deletion of p53.
4
Recently, it has been shown that bortezomib treatment enhances OB function.
5
The safety profile was consistent with that reported for single-agent bortezomib and romidepsin.
6
These data suggest that bortezomib-induced plasma cell depletion triggers humoral compensation.
7
We tested the signature in independent cohorts treated with bortezomib- and lenalidomide-based therapies.
8
After repeated treatment, initially sensitive lung tumors became resistant to bortezomib.
9
The synergistic interaction between oHSV and bortezomib was calculated using a Chou-Talalay analysis.
10
The combination of bortezomib and IFN-a can be safely administered to melanoma patients.
11
The proteasome inhibitor bortezomib is an efficacious apoptotic agent in many tumor cells.
12
The degree of proteasome inhibition was similar to that reported with single-agent bortezomib.
13
When possible, all subsequent doses of bortezomib within each cycle were provided at home.
14
Conversely, none of the patients who received a treatment without bortezomib developed muscular symptoms.
15
Conclusion: Both bortezomib plus rituximab regimens seem feasible in relapsed or refractory indolent lymphomas.
16
This delineates another therapeutic mechanism of bortezomib in T-cell malignancies.
Sobre aquest terme
Col·locacions frequents
Més col·locacions
Bortezomib a través del temps
Bortezomib per variant geogràfica
Estats Units d'Amèrica
Comú